The Autoimmune Disease Diagnosis Market is predicted to reach US$ ~3.95 billion by 2031 from US$ ~9.79 billion in 2020, and to grow at a CAGR of ~8.6% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Product (Instruments and Consumables & Assay Kits), Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Test Type (Routine Laboratory Tests, Autoantibodies & Immunologic Test, and Inflammatory Markers)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, Abbott, Trinity Biotech Plc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., bioMérieux SA, Euroimmun Medizinische Labordiagnostika AG (a PerkinElmer company), and Inova Diagnostics, Inc., among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2018 & 2019
2. Base Year - 2020
3. Forecasted Years - 2021 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY REGION
North America Autoimmune Disease Diagnosis Market
1. North America Autoimmune Disease Diagnosis Market, by Country
1. US
2. Canada
1. North America Autoimmune Disease Diagnosis Market, by Product
2. North America Autoimmune Disease Diagnosis Market, by Type
3. North America Autoimmune Disease Diagnosis Market, by Gender
4. North America Autoimmune Disease Diagnosis Market, by Sales Channel
3. Europe Autoimmune Disease Diagnosis Market
1. Europe Autoimmune Disease Diagnosis Market, by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Autoimmune Disease Diagnosis Market, by Product
3. Europe Autoimmune Disease Diagnosis Market, by Type
4. Europe Autoimmune Disease Diagnosis Market, by Gender
5. Europe Autoimmune Disease Diagnosis Market, by Sales Channel
4. Asia Pacific Autoimmune Disease Diagnosis Market
1. Asia Pacific Autoimmune Disease Diagnosis Market, by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Autoimmune Disease Diagnosis Market, by product
3. Asia Pacific Autoimmune Disease Diagnosis Market, by Type
4. Asia Pacific Autoimmune Disease Diagnosis Market, by Gender
5. Asia Pacific Autoimmune Disease Diagnosis Market, by Sales Channel
5. Rest of the World Autoimmune Disease Diagnosis Market
1. Rest of the World Autoimmune Disease Diagnosis Market, by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Autoimmune Disease Diagnosis Market, by Product
3. Rest of the World Autoimmune Disease Diagnosis Market, by Type
4. Rest of the World Autoimmune Disease Diagnosis Market, by Gender
5. Rest of the World Autoimmune Disease Diagnosis Market, by Sales Channel
2. COMPANY PROFILES
Company 1, Company 7